BOLT · Categories · Form 4

BOLT - SEC Form 4 insider transactions

Bolt Biotherapeutics Inc. (BOLT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for BOLT

• 118d
  SEC Form 4 filed by Chief Operating Officer Yonehiro Grant

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 168d
  SEC Form 4 filed by Director Dupont Jakob

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 168d
  SEC Form 4 filed by Director Onetto Nicole

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 168d
  SEC Form 4 filed by Director Berner Laura

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 168d
  SEC Form 4 filed by Director Laporte Kathleen

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 168d
  SEC Form 4 filed by Director O'Callaghan Brian

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 168d
  SEC Form 4 filed by Senior VP, Finance and PAO Nemec Sarah

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 168d
  SEC Form 4 filed by Chief Operating Officer Yonehiro Grant

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 168d
  SEC Form 4 filed by President, CEO and CFO Quinn William P.

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 221d
  Chief Operating Officer Yonehiro Grant was granted 30,000 shares, increasing direct ownership by 336% to 38,918 units (SEC Form 4)

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 336d
  SEC Form 4 filed by Director Dupont Jakob

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 336d
  SEC Form 4 filed by Director Berner Laura

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 336d
  SEC Form 4 filed by Director Onetto Nicole

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 336d
  SEC Form 4 filed by Director Laporte Kathleen

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 336d
  SEC Form 4 filed by Director O'Callaghan Brian

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 393d
  SEC Form 4 filed by Director Dupont Jakob

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 393d
  SEC Form 4 filed by Chief Operating Officer Yonehiro Grant

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 635d
  SEC Form 4 filed by Director Dupont Jakob

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 678d
  SEC Form 4 filed by Chief Operating Officer Yonehiro Grant

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 678d
  SEC Form 4 filed by President, CEO and CFO Quinn William P.

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 678d
  SEC Form 4 filed by VP, Finance and PAO Nemec Sarah

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 718d
  SEC Form 4 filed by Director Shah Mahendra

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 718d
  SEC Form 4 filed by Director Onetto Nicole

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 718d
  SEC Form 4 filed by Director O'Callaghan Brian

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 718d
  SEC Form 4 filed by Director Lee Frank D.

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 718d
  SEC Form 4 filed by Director Laporte Kathleen

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 718d
  SEC Form 4 filed by Director Healy James

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 718d
  SEC Form 4 filed by Director Berner Laura

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 819d
  SEC Form 4 filed by Yonehiro Grant

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 819d
  SEC Form 4 filed by Perez Edith A.

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 819d
  SEC Form 4 filed by Schatzman Randall C

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 819d
  SEC Form 4 filed by Quinn William P.

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 915d
  Engleman Edgar sold $128,993 worth of shares (148,884 units at $0.87) (SEC Form 4)

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 923d
  Engleman Edgar sold $1,751 worth of shares (1,943 units at $0.90) (SEC Form 4)

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 923d
  Vivo Capital Viii, Llc sold $3,060 worth of shares (3,400 units at $0.90) (SEC Form 4)

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 925d
  Engleman Edgar sold $45,675 worth of shares (49,173 units at $0.93) (SEC Form 4)

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 925d
  Vivo Capital Viii, Llc sold $7,636 worth of Comon Stock (8,211 units at $0.93) and sold $72,297 worth of shares (77,843 units at $0.93) (SEC Form 4)

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1084d
  SEC Form 4 filed by Shah Mahendra

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1084d
  SEC Form 4 filed by Onetto Nicole

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1084d
  SEC Form 4 filed by O'Callaghan Brian

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1084d
  SEC Form 4 filed by Miller Richard A Md

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1084d
  SEC Form 4 filed by Lee Frank D.

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1084d
  SEC Form 4 filed by Laporte Kathleen

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1084d
  SEC Form 4 filed by Healy James

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1084d
  SEC Form 4 filed by Engleman Edgar

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1084d
  SEC Form 4 filed by Berner Laura

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1190d
  SEC Form 4 filed by Yonehiro Grant

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1190d
  SEC Form 4 filed by Perez Edith A.

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1190d
  SEC Form 4 filed by Schatzman Randall C

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1190d
  SEC Form 4 filed by Quinn William P.

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1265d
  SEC Form 4 filed by Miller Richard A Md

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1265d
  SEC Form 4 filed by Laporte Kathleen

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1265d
  SEC Form 4 filed by Berner Laura

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1418d
  SEC Form 4: Novo Holdings A/S sold $1,600,000 worth of shares (800,000 units at $2.00), decreasing direct ownership by 18% to 3,703,991 units

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1453d
  SEC Form 4 filed by Shah Mahendra

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1453d
  SEC Form 4 filed by Onetto Nicole

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1453d
  SEC Form 4 filed by O'Callaghan Brian

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1453d
  SEC Form 4 filed by Miller Richard A Md

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1453d
  SEC Form 4 filed by Lee Frank D.

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)
• 1453d
  SEC Form 4 filed by Laporte Kathleen

  4 - Bolt Biotherapeutics, Inc. (0001641281) (Issuer)

Other BOLT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends